In a clinical trial studying liraglutide, nausea affected 24.7% of participants at week 4, but this number dropped to just 5.5% by week 56
1 and Supplementary Table 2
But which drug proves to be better depends on the patients response to the drug, current health, dosage recommended, and adherence to diet and exercise regime
If a specific approved medication is part of a clinician-led discussion, product pages such as Zepbound, Wegovy, or Ozempic Semaglutide Pens can help readers identify the type of product being discussed
Set phone reminders if needed
Side Effect CJC-1295 + Ipamorelin HGH (Somatropin) Injection site reactions Common, mild Common, mild Water retention/edema Mild, transient Moderate to significant, dose-dependent Joint pain Rare Common at higher doses (carpal tunnel, arthralgia) Insulin resistance Not documented as significant Well-documented at supraphysiological doses Cortisol elevation Minimal (Ipamorelin is selective) Not directly caused by HGH Prolactin elevation Minimal (Ipamorelin advantage over GHRP-2/6) Not directly caused by HGH Organ enlargement risk Not documented (physiological GH levels) Documented at chronic supraphysiological doses Pituitary suppression Feedback loop preserved Natural GH production suppressed with prolonged use The side effect differential largely stems from the feedback loop distinction